Safety and Efficacy of Topical AR/101 Compared With Placebo, in Accelerating Granulation Tissue Formation of Hard-to-heal Wounds
Phase 2
- Conditions
- Other Ulcers Wounds and Skin ProblemsWounds
- Interventions
- Drug: PlaceboDrug: AR/101
- First Posted Date
- 2016-07-20
- Last Posted Date
- 2016-07-20
- Lead Sponsor
- Arava Bio Tech Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT02839226
- Locations
- 🇮🇱
Sourasky Medical Center, Tel Aviv, Israel
Safety and Efficacy of AR/101 in Accelerating Re-epithelialization of Split Thickness Wounds
Phase 2
- Conditions
- Wounds and Injuries
- Interventions
- Drug: AR/101Drug: Placebo
- First Posted Date
- 2015-11-11
- Last Posted Date
- 2016-07-19
- Lead Sponsor
- Arava Bio Tech Ltd.
- Target Recruit Count
- 18
- Registration Number
- NCT02602184
- Locations
- 🇺🇸
Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
© Copyright 2025. All Rights Reserved by MedPath